SS-31 – A Mitochondria-Targeted Research Peptide
Every cell in our body needs energy to function properly. The main source of this energy is mitochondria – cellular organelles that convert nutrients into ATP, the molecule providing energy for all biological processes.
If mitochondrial function is impaired, it can lead to decreased energy production, increased oxidative stress, and progressive cell damage. This is precisely why significant attention has been paid in recent years to research into substances that target mitochondria directly. One of the most interesting molecules is SS-31 (Elamipretide).
What is SS-31?
SS-31 is a synthetic tetrapeptide designed for targeted interaction with mitochondria. Unlike many other peptides, it does not act through classical receptors but binds to cardiolipin, a specific phospholipid found in the inner mitochondrial membrane.
This very property makes SS-31 an important object of research focused on cellular energetics, oxidative stress, and the preservation of mitochondrial function.
Why is SS-31 the subject of intensive research?
Mitochondria are essential for the proper functioning of almost all tissues in the body. Organs with high energy demands, such as the heart, brain, skeletal muscles, or kidneys, are particularly dependent on their proper function.
In laboratory studies, SS-31 is primarily investigated for its potential impact on:
- mitochondrial function,
- cellular energy metabolism,
- mechanisms of oxidative stress,
- cell regeneration,
- muscle physiology,
- neurobiological research,
- cardiovascular research.
Results of preclinical studies
Experimental studies in animal models suggest that SS-31 may contribute to preserving mitochondrial structure and supporting their energy efficiency.
In models of acute kidney injury, researchers observed a reduction in markers of oxidative stress and inflammation, along with the preservation of renal tissue structure.
In the field of cardiovascular research, SS-31 has also been studied in connection with the restoration of mitochondrial function after ischemic damage to the heart muscle.
SS-31 and muscle energy
One of the most cited studies published in the journal Aging Cell investigated the effects of SS-31 on skeletal muscle mitochondria in older laboratory mice.
After a single dose, researchers observed an improvement in several indicators related to cellular energy production. Mitochondria showed higher efficiency in ATP formation, and their energy capacity approached values observed in younger individuals.
These results contribute to the growing interest in the use of mitochondria-targeted peptides in research on aging and muscle physiology.
Research in the nervous system
SS-31 is also being investigated in preclinical models of nervous tissue injury.
In some studies, its administration led to a reduction in markers of oxidative stress, limitation of mitochondrial damage, and preservation of cellular integrity after experimental brain injury.
These results support further research focused on neurobiology and mechanisms of cellular protection.
Summary
SS-31 represents one of the most studied mitochondria-targeted peptides today. Thanks to its unique mechanism of action, it is the subject of intensive laboratory research in the areas of cellular energetics, muscle physiology, neurosciences, cardiovascular research, and aging research.
Although the current preclinical results look promising, further studies are needed to better understand its biological properties and potential future applications.
For research purposes only
SS-31 offered by MX Peptides is intended exclusively for laboratory and research purposes. It is not approved for human use, diagnosis, or treatment of diseases.